SYK
Stryker Corporation
Health Care · Health Care Equipment · US
✓ ETHICAL PASS
MODERATE MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$117.7B
Total market value of the company
35.49
Expensive — high growth expected
18.37
Based on estimated future earnings — lower means cheaper
Rev Growth
+2.6%
Year-over-year revenue change
Profit Margin
13.2%
How much profit the company keeps from each dollar of revenue
15.2%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$389.35
+27% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 26 analysts covering this stock
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
https://www.stryker.com
Country: United States Employees: 56,000 Industry: Medical Devices
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
33.1% PASS
Debt must be below 33% of total assets
Cash Ratio
0.2% PASS
Interest-bearing cash below 33% of assets
Receivables
16.8% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$200.55
What our model estimates this business is worth per share
-52.4%
Trading above fair value — no margin of safety
Rating
OVERVALUED
Overall assessment combining ethics, valuation, and quality
94.4th
Ranks in the top 6% of our 13,571 screened universe
Trading at $307, 53% above fair value of $201. Moderate competitive position. Passes all ethical screens. Ranks better than 55% of screened stocks.
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
DISTRIBUTION
Smart money appears to be selling into strength — caution
-0.032
Returns do not compensate for the risk — negative edge
-0.0048
No positive edge detected — the data suggests staying out
-0.104
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-3.1%
Historical annualised return based on price data
-29.5%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
1
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
0.81
Less volatile than the market — more defensive
52W High
$404.87
25% below the year high
52W Low
$281.00
9% above the year low
Avg Volume
2,207,491
Average daily shares traded — higher means easier to buy and sell
2.3
Days it would take all short sellers to cover — higher means more crowded
Short % Float
1.2%
Low short interest — limited bearish positioning
1.2%
Annual dividend as a percentage of the share price
$8.65
Earnings per share over the last 12 months
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
0.66
Moderate leverage — manageable
2.11
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
1.04
Like current ratio but excludes inventory — stricter test
Gross Margin
64.7%
Revenue left after cost of goods — higher means pricing power
Operating Margin
17.8%
Profit from core operations before interest and tax
$4.4B
Positive — the business generates more cash than it spends
Revenue (TTM)
$25.3B
Total revenue over the last 12 months
Net Income
$3.3B
Profitable — the bottom line is positive
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
55
NEUTRAL
Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Politicians have been buying this name.
| Date |
Insider |
Title |
Type |
Shares |
Value |
| 2026-05-11 |
FINK MARY KATHRYN |
Officer |
|
8,720 |
$2,473,756 |
| 2026-05-08 |
FINK MARY KATHRYN |
Officer |
|
21,582 |
$3,625,388 |
| 2026-05-06 |
MACEDA EMMANUEL PEREZ |
Director |
|
762 |
— |
| 2026-05-06 |
KING DEBRA |
Chief Technology Officer |
|
1,016 |
— |
| 2026-05-06 |
SKEETE TATUM LISA M |
Director |
|
762 |
— |
| 2026-05-06 |
CAFORIO GIOVANNI |
Director |
|
762 |
— |
| 2026-05-06 |
RUGGERI RACHEL |
Director |
|
762 |
— |
| 2026-05-06 |
MONTAGNINO KIMBERLY ANN |
Officer |
|
677 |
— |
| 2026-05-06 |
STRYKER RONDA E |
Director |
|
762 |
— |
| 2026-05-06 |
SILVERNAIL ANDREW K. |
Director |
|
762 |
— |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date |
Politician |
Party |
Type |
Amount |
| 2026-04-24 |
Ro Khanna |
Democrat |
Purchase |
1K–15K |
| 2026-04-13 |
Ro Khanna |
Democrat |
Purchase |
15K–50K |
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15